[{"NetIncomeLoss_4_FY_USD":-161381000.0,"EffectiveIncomeTaxRateReconciliationOtherAdjustments_4_FY_pure":-0.009,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_FY_USD":10.83,"GeneralAndAdministrativeExpense_4_FY_USD":45321000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_4_FY_shares":61842722.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_0_FY_USD":107753000.0,"CommitmentsAndContingencies_0_FY_USD":null,"AccruedLiabilitiesCurrent_0_FY_USD":29199000.0,"RestrictedCashCurrent_0_FY_USD":210000.0,"PaymentsToAcquireShortTermInvestments_4_FY_USD":430211000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_FY_USD":-34000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_FY_USD":52394000.0,"IncomeTaxesPaid_4_FY_USD":482000.0,"NetCashProvidedByUsedInInvestingActivities_4_FY_USD":-23444000.0,"Depreciation_4_FY_USD":2405000.0,"OperatingLeaseLiability_0_FY_USD":6985000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_4_FY_shares":3794735.0,"DividendsCommonStockCash_4_FY_USD":0.0,"IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_4_FY_USD":0.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_FY_USD":2065000.0,"AssetsCurrent_0_FY_USD":333249000.0,"CashCollateralForBorrowedSecurities_0_FY_USD":210000.0,"DeferredTaxAssetsOperatingLossCarryforwards_0_FY_USD":198000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_4_FY_shares":10164170.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_FY_USD":3055000.0,"DeferredTaxAssetsTaxCreditCarryforwardsResearch_0_FY_USD":1674000.0,"UnrecognizedTaxBenefits_0_FY_USD":837000.0,"Assets_0_FY_USD":349464000.0,"ShareBasedCompensation_4_FY_USD":20875000.0,"OperatingLeaseRightOfUseAsset_0_FY_USD":6566000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_4_FY_USD":14.88,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_4_FY_USD":0.0,"DeferredCosts_0_FY_USD":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_4_FY_USD":19.15,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_4_FY_USD":-67000.0,"ShortTermInvestments_0_FY_USD":209444000.0,"IncreaseDecreaseInOtherNoncurrentAssets_4_FY_USD":5588000.0,"ResearchAndDevelopmentExpense_4_FY_USD":112042000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_FY_USD":13.53,"LesseeOperatingLeaseLiabilityPaymentsDue_0_FY_USD":7539000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_4_FY_shares":17995.0,"DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_0_FY_USD":634000.0,"IncreaseDecreaseInAccruedLiabilities_4_FY_USD":8797000.0,"IncomeTaxExpenseBenefit_4_FY_USD":5152000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_0_FY_USD":13.41,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_4_FY_USD":5754000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_4_FY_USD":13.09,"EffectiveIncomeTaxRateContinuingOperations_4_FY_pure":-0.033,"NetCashProvidedByUsedInFinancingActivities_4_FY_USD":227086000.0,"FairValueAssetsLevel2ToLevel1TransfersAmount_0_FY_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_4_FY_USD":0.0,"PaymentsOfStockIssuanceCosts_4_FY_USD":1136000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_0_FY_shares":6159004.0,"IncreaseDecreaseInOtherNoncurrentLiabilities_4_FY_USD":478000.0,"DefinedContributionPlanCostRecognized_4_FY_USD":993000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_4_FY_USD":12.95,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_0_FY_shares":205312.0,"Liabilities_0_FY_USD":37529000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_0_FY_USD":15.19,"OperatingLeaseLiabilityNoncurrent_0_FY_USD":4878000.0,"OtherAssetsNoncurrent_0_FY_USD":5588000.0,"IncreaseDecreaseInAccountsPayable_4_FY_USD":-4969000.0,"ComprehensiveIncomeNetOfTax_4_FY_USD":-161448000.0,"UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_4_FY_USD":102000.0,"EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_4_FY_pure":-0.024,"CashCashEquivalentsAndShortTermInvestments_0_FY_USD":323482000.0,"CashAndCashEquivalentsAtCarryingValue_0_FY_USD":114038000.0,"DeferredIncomeTaxAssetsNet_0_FY_USD":10000.0,"DeferredTaxAssetsNet_0_FY_USD":10000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_FY_USD":554000.0,"RetainedEarningsAccumulatedDeficit_0_FY_USD":-517473000.0,"CurrentIncomeTaxExpenseBenefit_4_FY_USD":791000.0,"LeaseCost_4_FY_USD":1745000.0,"CurrentForeignTaxExpenseBenefit_4_FY_USD":33000.0,"DeferredTaxAssetsGross_0_FY_USD":11749000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_FY_USD":4730000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_4_FY_USD":-67000.0,"OperatingLossCarryforwards_0_FY_USD":0.0,"EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_4_FY_pure":-0.057,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4_FY_USD":-156229000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_4_FY_USD":20875000.0,"NetCashProvidedByUsedInOperatingActivities_4_FY_USD":-136532000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_FY_USD":2419000.0,"LiabilitiesCurrent_0_FY_USD":31846000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_4_FY_USD":67110000.0,"AccountsPayableCurrent_0_FY_USD":503000.0,"EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_4_FY_pure":0.006,"PropertyPlantAndEquipmentNet_0_FY_USD":4051000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_FY_USD":31526000.0,"EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_4_FY_pure":0.013,"StockIssuedDuringPeriodSharesStockOptionsExercised_4_FY_shares":1324429.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_4_FY_shares":80701.0,"AdditionalPaidInCapital_0_FY_USD":829424000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_FY_shares":3799854.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_FY_pure":0.056,"OtherAccruedLiabilitiesCurrent_0_FY_USD":562000.0,"EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_4_FY_pure":-0.008,"UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_4_FY_USD":411000.0,"ProceedsFromStockOptionsExercised_4_FY_USD":6553000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_FY_USD":9557000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_FY_USD":114248000.0,"EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_4_FY_pure":0.0,"AccruedProfessionalFeesCurrent_0_FY_USD":3988000.0,"VariableLeaseCost_4_FY_USD":167000.0,"EffectiveIncomeTaxRateReconciliationTaxContingenciesStateAndLocal_4_FY_pure":0.001,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_4_FY_USD":1334000.0,"FairValueAssetsLevel1ToLevel2TransfersAmount_0_FY_USD":0.0,"OperatingIncomeLoss_4_FY_USD":-157363000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_4_FY_USD":-156229000.0,"InvestmentIncomeInterest_4_FY_USD":1134000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_4_FY_USD":16.5,"DeferredIncomeTaxExpenseBenefit_4_FY_USD":4361000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_4_FY_USD":4.57,"OperatingLeaseCost_4_FY_USD":1578000.0,"LiabilitiesAndStockholdersEquity_0_FY_USD":349464000.0,"EmployeeRelatedLiabilitiesCurrent_0_FY_USD":7704000.0,"AllocatedShareBasedCompensationExpense_4_FY_USD":20875000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_4_FY_shares":60278.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_4_FY_shares":1003182.0,"DeferredTaxAssetsValuationAllowance_0_FY_USD":9307000.0,"PropertyPlantAndEquipmentGross_0_FY_USD":8781000.0,"OperatingLeaseLiabilityCurrent_0_FY_USD":2107000.0,"AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition_4_FY_USD":6552000.0,"DeferredForeignIncomeTaxExpenseBenefit_4_FY_USD":-10000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_4_FY_USD":407050000.0,"DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_0_FY_USD":6271000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_4_FY_USD":-123000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_4_FY_USD":-161983000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_FY_shares":9958858.0,"PaymentsToAcquirePropertyPlantAndEquipment_4_FY_USD":283000.0,"OtherLiabilitiesCurrent_0_FY_USD":37000.0,"OtherLiabilitiesNoncurrent_0_FY_USD":805000.0,"ProfitLoss_4_FY_USD":-161381000.0,"EarningsPerShareBasicAndDiluted_4_FY_USD":-2.61,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_4_FY_USD":6039000.0,"OperatingExpenses_4_FY_USD":157363000.0,"StockholdersEquity_0_FY_USD":311935000.0,"PurchaseCommitmentRemainingMinimumAmountCommitted_0_FY_USD":16178000.0,"Ticker":"KNSA","CIK":"1730430","name":"KINIKSA PHARMACEUTICALS, LTD.","OfficialName":"Kiniksa Pharmaceuticals Ltd. Class A Common Stock","form":"10-K","period":"20201231","fy":"2020.0","fp":"FY","qtrs":"4","uom":"USD","footnote":"nan","Market Cap":"764985918.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210225"}]